Oragenics
OGEN
25 hedge funds and large institutions have $9.98M invested in Oragenics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
176% more capital invested
Capital invested by funds: $3.61M → $9.98M (+$6.37M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
4% more funds holding
Funds holding: 24 → 25 (+1)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$35.8K |
| 2 |
Renaissance Technologies
New York
|
+$35.8K |
| 3 |
Charles Schwab
San Francisco,
California
|
+$32.3K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$28.9K |
| 5 |
LA
LexAurum Advisors
Overland Park,
Kansas
|
+$9.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.2K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 3 |
BSW
Buckingham Strategic Wealth
Clayton,
Missouri
|
-$9K |
| 4 |
Jane Street
New York
|
-$4.62K |
| 5 |
VF
Virtu Financial
New York
|
-$4.62K |
OGEN Hedge Fund Activity: Q2 2022 in Review
25 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2022, worth a combined $9.98M — up 176% from $3.61M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OGEN positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, adding an estimated $35.8K. The largest seller was Susquehanna International Group, cutting an estimated $16.2K.
- 25 institutional investors held Oragenics (OGEN) as of Q2 2022, up from 24 in Q1 2022.
- Funds reported $9.98M of Oragenics stock for Q2 2022, up 176% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q2 2022 was Millennium Management, an estimated $35.8K added.
- The largest Oragenics seller in Q2 2022 was Susquehanna International Group, an estimated $16.2K sold.
Based on aggregated 13F filings for Q2 2022.